Stock Screener App

Gratuito -

Installare

3.09

0.64% -0.02

after-market

Dopo l'orario di chiusura: 3.09

Maravai Lifesciences Holdings Inc (MRVI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MRVI Giù? Forum Previsione

Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie

Recap Report: What is the dividend yield of Maravai LifeSciences Holdings IncGDP Growth & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Aug Gainers: How cyclical is CSWCs revenue stream2026 Analyst Calls & Capital Efficiency Focused Ideas - baoquankhu1.vn

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Stop Loss: What are Maravai LifeSciences Holdings Incs earnings expectationsEarnings Performance Report & Long-Term Capital Growth Strategies - baoquankhu1.vn

Maravai LifeSciences stock faces ongoing volatility amid restructuring efforts and biotech sector pr - AD HOC NEWS

Analysts’ Top Technology Picks: Blaize Holdings (BZAI), Zeta Global Holdings Corp (ZETA) - The Globe and Mail

Published on: 2026-03-25 14:27:07 - baoquankhu1.vn

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Class Action Filed Against Maravai LifeSciences Holdings, Inc. (M - The National Law Review

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat

Maravai LifeSciences Holdings, Inc. (MRVI) reports Q4 loss, beats revenue estimates - MSN

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

[Form 4] MARAVAI LIFESCIENCES HOLDINGS, INC. Insider Trading Activity - Stock Titan

Maravai (MRVI) General Counsel has 39,976 shares withheld for taxes - Stock Titan

Maravai LifeSciences (NASDAQ:MRVI) Sees Large Volume IncreaseStill a Buy? - MarketBeat

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

2026-03-15 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation | NDAQ:MRVI | Press Release - Stockhouse

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - ACCESS Newswire

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire

Maravai LifeSciences Holdings Q1 2025 Earnings Preview - MSN

2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out | NDAQ:MRVI | Press Release - Stockhouse

How rising interest rates impact Maravai LifeSciences Holdings Inc. stockEntry Point & Precise Trade Entry Recommendations - Naître et grandir

How does Maravai LifeSciences Holdings Inc score in quality rankings2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn

Targets Report: What are Maravai LifeSciences Holdings Incs earnings expectations2025 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat

Royce & Associates LP Has $5.06 Million Stock Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat

First Eagle Investment Management LLC Makes New Investment in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat

MRVI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

MRVI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Maravai Lifesciences Charts Early Turnaround in 2025 - TipRanks

Maravai LifeSciences (NASDAQ:MRVI) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing a Potential 14% Upside in the Biotechnology Sector - DirectorsTalk Interviews

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Maravai Lifesciences Holdings (MRVI) and Sarepta Therapeutics (SRPT) - The Globe and Mail

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap UpStill a Buy? - MarketBeat

Is Maravai LifeSciences Holdings Inc.’s ROE strong enoughMarket Growth Report & Fast Exit and Entry Trade Guides - mfd.ru

Maravai Q4 2025 slides: return to positive EBITDA on cost cuts - Investing.com Nigeria

Maravai LifeSciences Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Maravai LifeSciences Holdings Inc (MRVI) Q4 2025 Earnings Call Highlights: Surpassing Revenue ... By GuruFocus - Investing.com Canada

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results - BioSpace

Maravai LifeSciences Q4 Earnings Call Highlights - MarketBeat

Maravai LifeSciences Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:MRVI) 2026-02-26 - Seeking Alpha

Maravai LifeSciences Holdings Inc (MRVI) Q4 2025 Earnings Call H - GuruFocus

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Maravai Q4 2025 slides: return to positive EBITDA on cost cuts By Investing.com - Investing.com South Africa

Earnings call transcript: Maravai Lifesciences Q4 2025 beats EPS forecast, stock jumps 4.5% - Investing.com Canada

MRVI: 2025 saw revenue beat, margin recovery, and strong 2026 growth and profitability guidance - TradingView

Maravai LifeSciences Holdings Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Maravai LifeSciences (NASDAQ:MRVI) Issues Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

Maravai LifeSciences Holdings, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com

MRVI Projects FY26 Adjusted EBITDA Between $18M and $20M - GuruFocus

Maravai LifeSciences (MRVI) Surpasses Revenue Expectations in Q4 - GuruFocus

Maravai LifeSciences (NASDAQ: MRVI) posts 2025 loss but targets 2026 EBITDA rebound - Stock Titan

Maravai LifeSciences Q4 2025 Earnings Call Transcript - MarketBeat

ROIV

$27.35

0.04%

RPRX

$46.94

0.19%

MRNA

$53.57

0.06%

BNTX

$87.46

1.48%

ONC

$276.95

2.29%

INSM

$147.60

0.48%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters